
Sreemannarayana Murali Krishna Pasumarthi
About Sreemannarayana Murali Krishna Pasumarthi
Data last updated:
Sreemannarayana Murali Krishna Pasumarthi is a Managing Director at Intron Life Sciences Private Limited (since 2018), Whole-Time Director at Exome Life Sciences Private Limited (since 2017) and Director at Biome Biologicals Private Limited (since 2021), and holds 4 more current directorships. The companies operate in Life Sciences, Business Outsourcing and Hospitality & Wellness. The 6 current companies with reported revenue have a combined latest revenue of ₹151 Cr; the largest is Intron Life Sciences Private Limited at ₹103 Cr (FY 2025). Earlier, Sreemannarayana Murali Krishna Pasumarthi was a Director at Convergent Biosystems Private Limited (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 28 Sep 2018 | 2018 | ₹103 Cr (FY 2025) | Active | |
| Whole-Time Director | 07 Apr 2017 | 2017 | ₹27.22 Cr (FY 2023) | Active | |
| Director | 20 Jan 2021 | 2021 | ₹11.68 Cr (FY 2023) | Active | |
| Director | 06 Dec 2016 | 2016 | ₹5.77 Cr (FY 2025) | Active | |
| Director | 04 Sep 2015 | 2015 | ₹3.52 Cr (FY 2024) | Active | |
| Director | 21 Sep 2020 | 2020 | ₹3,600 (FY 2024) | Active | |
| Director | 28 Dec 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Nov 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sreemannarayana Murali Krishna Pasumarthi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Gupta | 06805265 | Intron Life Sciences Private Limited | Nominee Director |
| Pavan Kumar Velpuri | 07260879 | Intron Life Sciences Private Limited , Exome Life Sciences Private Limited and 3 more | Whole-Time Director |
| Ronak Modi | Intron Life Sciences Private Limited | Company Secretary | |
| Saranya Mukul Agrawal | 09682018 | Intron Life Sciences Private Limited | Nominee Director |
| Vijay Ramvallabh Khetan | 00465161 | Intron Life Sciences Private Limited | Nominee Director |
| Honey Lahoti | 08741200 | Exome Life Sciences Private Limited , Kph Infotech Private Limited and 1 more | Whole-Time Director |
| Nithyagovind | 08180238 | Biome Biologicals Private Limited | Nominee Director |
| Pio Barrios Castillo Jr | 07453316 | Ipi India Private Limited | Managing Director |
| Stanley Uang | 07453464 | Ipi India Private Limited | Director |
| Maurice Pierre Chaplais | 07570683 | Purplecow Foods Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sreemannarayana Murali Krishna Pasumarthi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sreemannarayana Murali Krishna Pasumarthi
Sreemannarayana Murali Krishna Pasumarthi currently holds 7 directorships: Intron Life Sciences Private Limited (Managing Director, since 28 Sep 2018, revenue ₹103 Cr (FY 2025)); Exome Life Sciences Private Limited (Whole-Time Director, since 07 Apr 2017, revenue ₹27.22 Cr (FY 2023)); Biome Biologicals Private Limited (Director, since 20 Jan 2021, revenue ₹11.68 Cr (FY 2023)); Ipi India Private Limited (Director, since 06 Dec 2016, revenue ₹5.77 Cr (FY 2025)); Purplecow Foods Private Limited (Director, since 04 Sep 2015, revenue ₹3.52 Cr (FY 2024)); and 2 more.
Sreemannarayana Murali Krishna Pasumarthi was first appointed on 04 Sep 2015 as Director at Purplecow Foods Private Limited. The most recent appointment on record is 28 Dec 2023 at Magma & Flowra Skin Care Private Limited.
The 6 current companies of Sreemannarayana Murali Krishna Pasumarthi that report revenue have a combined latest revenue of ₹151 Cr: Intron Life Sciences Private Limited ₹103 Cr (FY 2025); Exome Life Sciences Private Limited ₹27.22 Cr (FY 2023); Biome Biologicals Private Limited ₹11.68 Cr (FY 2023); Ipi India Private Limited ₹5.77 Cr (FY 2025); Purplecow Foods Private Limited ₹3.52 Cr (FY 2024); and 1 more.
Sreemannarayana Murali Krishna Pasumarthi held 1 earlier board appointment: Convergent Biosystems Private Limited (Director, from 08 Nov 2021).
The current boards of Sreemannarayana Murali Krishna Pasumarthi's companies include Manish Gupta (Intron Life Sciences Private Limited), Pavan Kumar Velpuri (Intron Life Sciences Private Limited), Ronak Modi (Intron Life Sciences Private Limited), Saranya Mukul Agrawal (Intron Life Sciences Private Limited), Vijay Ramvallabh Khetan (Intron Life Sciences Private Limited), Honey Lahoti (Exome Life Sciences Private Limited), among others.